PMC:7558914 / 20978-21248 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"531","span":{"begin":173,"end":181},"obj":"Species"},{"id":"532","span":{"begin":193,"end":200},"obj":"Species"},{"id":"547","span":{"begin":71,"end":90},"obj":"Disease"},{"id":"548","span":{"begin":96,"end":109},"obj":"Disease"},{"id":"549","span":{"begin":164,"end":172},"obj":"Disease"}],"attributes":[{"id":"A531","pred":"tao:has_database_id","subj":"531","obj":"Tax:9606"},{"id":"A532","pred":"tao:has_database_id","subj":"532","obj":"Tax:9606"},{"id":"A547","pred":"tao:has_database_id","subj":"547","obj":"MESH:D060085"},{"id":"A548","pred":"tao:has_database_id","subj":"548","obj":"MESH:D006943"},{"id":"A549","pred":"tao:has_database_id","subj":"549","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The potential harm, such as delayed viral clearance, increased risk of secondary infection, and hyperglycemia episodes, have led to caution in their routine use in COVID-19 patients unless the patient had other conditions for which these are indicated [3,4,18,19,20,21]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T37","span":{"begin":96,"end":109},"obj":"Phenotype"}],"attributes":[{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0003074"}],"text":"The potential harm, such as delayed viral clearance, increased risk of secondary infection, and hyperglycemia episodes, have led to caution in their routine use in COVID-19 patients unless the patient had other conditions for which these are indicated [3,4,18,19,20,21]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T136","span":{"begin":0,"end":270},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The potential harm, such as delayed viral clearance, increased risk of secondary infection, and hyperglycemia episodes, have led to caution in their routine use in COVID-19 patients unless the patient had other conditions for which these are indicated [3,4,18,19,20,21]."}